Brendan Technologies

Brendan Technologies was a specialized provider of bioinformatics software for the life sciences industry, primarily focused on immunoassay data analysis. The company's core product, StatLIA, provided advanced curve-fitting and statistical analysis capabilities for assays such as ELISA, RIA, and multiplexing. This software was widely recognized for its ability to handle complex data sets and provide high-precision results in both clinical and research settings. By automating the analysis process, Brendan Technologies helped laboratories reduce errors and improve throughput. In 2007, the company was acquired by Molecular Devices, a leader in bioanalytical systems. The acquisition allowed Molecular Devices to integrate Brendan's industry-leading analysis algorithms directly into its microplate reader software suites.